APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer

Manikandan Periyasamy(Hammersmith Hospital), Hetal Patel(Hammersmith Hospital), Chun‐Fui Lai(Hammersmith Hospital), Van T.M. Nguyen(Hammersmith Hospital), Ekaterina Nevedomskaya(The Netherlands Cancer Institute), Alison Harrod(Hammersmith Hospital), Roslin Russell(Cancer Research UK), Judit Reményi(University of Dundee), Anna Maria Ochocka(Hammersmith Hospital), Ross S. Thomas(Hammersmith Hospital), Frances V. Fuller-Pace(University of Dundee), Balázs Győrffy(Semmelweis University), Carlos Caldas(Cancer Research UK), Naveenan Navaratnam(Hammersmith Hospital), Jason S. Carroll(Cancer Research UK), Wilbert Zwart(The Netherlands Cancer Institute), R. Charles Coombes(Hammersmith Hospital), Luca Magnani(Hammersmith Hospital), Laki Buluwela(Hammersmith Hospital), Simak Ali(Hammersmith Hospital)
Cell Reports
September 24, 2015
Cited by 117Open Access
Full Text

Abstract

Estrogen receptor α (ERα) is the key transcriptional driver in a large proportion of breast cancers. We report that APOBEC3B (A3B) is required for regulation of gene expression by ER and acts by causing C-to-U deamination at ER binding regions. We show that these C-to-U changes lead to the generation of DNA strand breaks through activation of base excision repair (BER) and to repair by non-homologous end-joining (NHEJ) pathways. We provide evidence that transient cytidine deamination by A3B aids chromatin modification and remodelling at the regulatory regions of ER target genes that promotes their expression. A3B expression is associated with poor patient survival in ER+ breast cancer, reinforcing the physiological significance of A3B for ER action.


Related Papers

No related papers found

Powered by citation graph analysis